National Oxygen Board to Discuss Preferential Share Issue April 29

National Oxygen Limited's Board of Directors is set to meet on April 29, 2026. The primary focus will be a proposal to issue up to 9,50,000 equity shares through a preferential offer.

Key Agenda Items

The board will also discuss setting the issue price for these shares. Additionally, it will consider approving a notice for an Extra-Ordinary General Meeting (EGM), along with appointing agencies for e-voting and scrutinizers.

Why This Matters

A preferential issue allows companies to raise capital by selling shares to specific investors at a set price. For National Oxygen, this could provide a vital capital injection to improve its financial standing. However, these issues can dilute existing shareholders' ownership. The price set and shareholder approval at the EGM will be crucial in determining the impact on the company's capital structure and who holds ownership.

Company Background

National Oxygen Limited, established in 1974, manufactures industrial gases like oxygen and nitrogen. The company has engaged in preferential share issuances previously, with approvals for similar issues to promoter group entities in March 2023 and again in March 2026. Saraf Housing Development Private Limited, a key promoter entity, has been involved in these transactions.

Financially, the company has faced difficulties, with recent losses and declining revenue. Its sales growth has been poor over the past five years, and earnings haven't covered interest expenses. The stock's price volatility has also drawn attention from exchanges.

Next Steps

Shareholders will now wait for the board's decision on the preferential issue and its terms. If approved, the plan will go to shareholders for final approval at the EGM. This process could inject needed capital into National Oxygen, improving its financial health. It might also lead to increased stake ownership by the promoter group, depending on the final price and allotment.

Investor Watchpoints

Key risks for investors include how the preferential issue price is determined by a registered valuer. This price must meet SEBI regulations and be approved by shareholders. Another major factor is the potential dilution of existing shares. Investors will also be watching the company's ongoing financial performance and its ability to use any new capital effectively.

Competitive Landscape

National Oxygen operates in the industrial gases sector, competing with larger players such as Linde India, Refex Industries Ltd., and Ellenbarrie Industrial Gases Ltd. These peers often benefit from greater scale, diversified product portfolios, and stronger financial footing, making National Oxygen a smaller participant in the market.

Recent Financials (Q3 FY2026)

• National Oxygen reported a revenue fall of -52.53% year-on-year to ₹5.15Cr in Q3 FY2026, with net profits at ₹-1.55Cr.
• The company's net profit margin fell by -64.93% year-on-year to -30.10% in Q3 FY2026.

What to Watch Next

• The outcome of the April 29, 2026, board meeting regarding the preferential issue proposal.
• The fixation of the preferential issue price by the appointed registered valuer.
• Shareholder approval for the preferential issue and EGM resolution.
• Details regarding the allottee(s) of the preferential shares and any changes in promoter shareholding.
• The company's subsequent financial results and operational performance.